ARTICLE | Clinical News
BioAlliance preclinical data
June 9, 2008 7:00 AM UTC
In a mouse model of melanoma, intramuscular AMEP reduced tumor growth by 53%. The peptide targets alpha-v-beta-3 (anb3) and alpha-5-beta-1 (a5b1). Data were presented at the American Society of Gene T...